A study was undertaken to retrospectively evaluate the yield of bronchoalveolar lavage (BAL) in a single-institution series of children after bone marrow transplantation (BMT) and to compare the yield of BAL between the ventilated and nonventilated patients. We reviewed charts of 52 consecutive children after BMT who underwent BAL. Thirty patients (41 BALs) were nonventilated (group 1) and 33 patients (45 BALs) were ventilated for respiratory failure (group 2). Eleven patients were included in both groups. BAL was performed a median of 255 and 28.5 days after BMT in groups 1 and 2, respectively (P Ͻ 0.001). Group 1: 17 pathogens were isolated from 13 BALs; a single pathogen from 10 BALs. Group 2: 15 pathogens were isolated from 14 BALs (31.1% positive). Viruses were isolated from 13 BALs in group 2. A severe complication of BAL occurred in only one patient from group 1 (1.1%). Open lung biopsies were performed in one patient in group 1 and eight patients in group 2. The histological findings correlated with the BAL findings in 66.7%. In conclusion, there was no difference in the yield of BAL between the groups. Therapy was changed in one third of the patients dictated by the BAL findings. The risk of severe complications was relatively low. A good correlation between open lung biopsy (OLB) and BAL was found. Bone Marrow Transplantation (2001) 27, 191-194. Keywords: bone marrow transplantation; bronchoalveolar lavage; pediatric intensive care unit; mechanical ventilation; respiratory failure Pulmonary complications occur in 40-60% of patients after bone marrow transplantation (BMT) and are responsible for an estimated 30% or more of BMT-related mortality.
cific. Although accurate diagnosis of pulmonary infections is crucial in these severely immunosuppressed patients, it is difficult to reach on the basis of 'pattern recognition' of pulmonary infiltrates on chest X-ray and computerized tomography. Several researchers have suggested that bronchoalveolar lavage (BAL) may be a safe and sensitive technique for the evaluation of lung infiltrates in these patients, and it has come into routine use for establishing the etiological agent in immunocompromised patients with pneumonia. [7] [8] [9] [10] The aims of the present study were to retrospectively evaluate a single-institution series of children after BMT who underwent BAL because of the presence of pulmonary infiltrates, and to compare the yield of BAL between the ventilated and nonventilated children.
Patients and methods
We reviewed the medical records of 52 consecutive children who underwent BMT at the Schneider Children's Medical Center of Israel in whom BAL was performed from 1 January 1995 to 1 June 1999 for the diagnosis of pulmonary infiltrates that failed to respond to empiric therapy. Table 1 summarizes the indications for BMT. For purposes of the study, the patients were divided into two groups: group 1 -nonventilated patients (30 patients, 41 BALs), and group 2 -patients who were receiving assisted ventilation for respiratory failure (33 patients, 45 BALs). Eleven patients were included in both groups as shown in Table 1 Indications for BMT Figure 1 . Chest radiograph changes ranged from local to diffuse interstitial infiltrates in all patients. Informed consent was obtained before the procedure from the patients or their parents for those who were less than 18 years old. An Olympus model BF3C30 flexible bronchoscope (Olympus Corp., Lake Success, NY, USA) with an external diameter of 3.6 mm was used. All of the children underwent BAL during hospitalization. In group 1, the procedure was performed under heavy sedation in a fully equipped bronchoscopy suite located in the Pediatric Intensive Care Unit. The sedation protocol consisted of intravenous midazolam, morphine, atropine, ketamine, and lidocaine hydrochloride. Local anesthesia was accomplished with lidocaine hydrochloride 2%. In addition, a combination of lignocaine hydrochloride 5% jelly with xylometazoline 0.1% was inserted into the nostrils for local anesthesia, lubrication and prevention of nasal bleeding. All BALs in this group were performed via a transnasal approach.
In group 2, the procedure was performed at the bedside in the Pediatric Intensive Care Unit. We used a flexible bronchoscope which was inserted via the endotracheal tube (endotracheal tubes size 4.5 or wider). In small infants (endotracheal tubes size less than 4.5), the BAL was performed via an end-hole catheter, which was inserted as deep as possible to wedge. During the procedure, the fractional concentration of oxygen inspired gas (FiO 2 ) was increased to 100%, and the positive inspiratory pressure was increased to maintain the pre-procedural pressure (to compensate for air leak). Local anesthesia was accomplished by instillation of 3-4 ml lidocaine hydrochloride 2% via the endotracheal tube, which was immediately suctioned, and instillation of this solution through the bronchoscope during the procedure as needed.
Thrombocytopenic patients underwent transfusion to achieve platelet counts above 50 × 10 9 /l; additional transfusions were given during the procedure to patients with resistant thrombocytopenia.
After brief inspection of the airways, the bronchoscope was wedged into the involved segments of the lungs, and BAL was performed with 3 to 5 aliquots of 0.5-1 ml/kg sterile isotonic saline. The lavaged fluid was collected into sterile traps and cultured for bacteria, including Mycobacteria, Mycoplasma and Chlamydia, for fungi, and for viruses. Direct staining for bacteria and fungi was also per- 
Results

Group 1: nonventilated patients
Forty-one BALs were performed in 30 patients after BMT. The median age of this group was 89 months (range 3.5-271 months). Twenty-five patients underwent allogeneic BMT and five received autologous transplants. The BALs were performed 1-1460 days after BMT (median 89 days). Seventeen pathogens were isolated from 13 BALs (31.7% positive BALs). A single pathogen was detected in 10 BALs (76.9% of the positive BALs), as follows: PCP -2, Aspergillus flavum -1, Hemophillus influenza -2, pneumococcus -1, CMV -2 and adenovirus -2. Figure 2 summarizes the pathogens detected in group 1. The results of BAL led to a change in specific therapy in 11 of the 13 patients, or 36.7% of the whole group (26.8% of whole BALs). Minor complications were found in some patients, including transient oxygen desaturation during and immediately after bronchoscopy which improved within a few hours of the procedure, and mild epistaxis which resolved with topical application of xylometazoline 0.1% or adrenaline. Only one patient in this group had a serious complication of BAL: a severe pulmonary hemorrhage developed a few hours following bronchoscopy which resulted in acute respiratory failure and the need for assisted venti- lation. This patient had severe GVHD and a bleeding diathesis. During the procedure, coagulation tests, including platelet count, were normal. Unfortunately, the patient died 2 weeks after the procedure.
Group 2: ventilated patients
Group 2 comprised 33 patients who were admitted to the Pediatric Intensive Care Unit for treatment of 40 episodes of acute respiratory failure which required assisted ventilation. Median age of this group was 42 months (range 40 days to 264 months). Twenty-seven patients underwent allogeneic BMT and six received an autologous transplant. The BALs were performed between 1 day and 515 days after BMT (median 28.5 days). In our center, all patients who need assisted ventilation undergo BAL. A total of 45 BALs were performed in 33 patients; nine patients underwent more than one. Twenty-four patients underwent one BAL early after admission; pathogens were isolated from eight (CMV -four, adenovirus -four). Five patients underwent two BALs during the same admission; the first BAL was negative in all of them, but in two patients the second BAL revealed CMV. Four patients needed multiple admissions to the Intensive Care Unit for treatment of respiratory failure and required assisted ventilation. Eleven BALs were performed and CMV was isolated from three BALs in this subgroup. The results of BAL led to a change in specific therapy in 10 patients, or 30.3% of the whole group (22.2% of whole BALs). Fifteen pathogens were isolated from 14 of the 46 BALs that were performed in patients of group 2 (31.1% were positive), and only viruses were isolated from 12 BALs in group 2. Figure 3 summarizes the isolates from group 2. Gancyclovir was given to all patients in whom CMV was isolated, and in those with persistent infection, foscarnet was added. All the patients in this group received broadspectrum antibiotics and many also received amphotericin B prior to admission to the Intensive Care Unit, which may explain the specific isolates from the BAL.
No serious peri-procedural complications were noted in the patients of group 2. Some needed greater oxygen supplementation after the procedure, but in all of them ventilator settings returned to baseline within a few hours. 
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Open lung biopsy
Open lung biopsy (OLB), was performed in one patient from group 1 and eight from group 2. Histologic findings correlated with the BAL results in six of the nine cases as shown in Table 2 . The BAL did not yield pathogens in two cases in which OLB showed busulfan lung and in one in which OLB showed diffuse alveolar damage. CMV pneumonitis was diagnosed in two OLBs; in both cases CMV was isolated from the BAL. Parainfluenza virus type 3 and adenovirus were isolated from respiratory secretions from a single patient with giant cell pneumonia. In two patients, OLB revealed interstitial pneumonia. CMV was isolated from the BAL of one of these patients, although it was not clear if CMV had a role in the pathogenesis of his respiratory disease. No infectious agent was detected in the BAL of patient No. 9, in whom OLB demonstrated inclusion bodies possibly indicating a viral infection. Therefore, discordance between BAL and OLB was found in 11.1% of patients (one of nine).
Discussion
The yield of BAL in ventilated and nonventilated BMT recipients with pulmonary infiltrates was evaluated in the present study. Over a 3.5-year period, 52 patients underwent 86 BALs for investigation of pulmonary infiltrates. Fifty-two (83.5%) of the tested patients had received allogeneic transplants. Allogeneic BMT recipients are known to develop pulmonary complications more frequently than autologous BMT recipients, and a greater proportion of them have respiratory failure mandating mechanical ventilation. This difference is likely related to the effect of GVHD and the intensive administration of immunosuppressive therapy. 1, 4 Infection is an important etiological factor in pulmonary infiltrates after BMT. Almost one-third of the BALs in both groups of the present study revealed a specific pathogen. Since all the patients included in the study received empiric antimicrobial treatment for lung infiltrates prior to BAL, we anticipated a lower yield than that seen in other studies, which ranges from 17 to 84%. 4, [7] [8] [9] [10] [11] [12] [13] The wide range of yield is probably a result of differences in prophylactic and empiric antimicrobial treatment policies among various centers as well as the timing of BAL in individual patients. There were significant and interesting differences in the pathogens detected between the ventilated and nonventilated patients. Viruses were detected in 13 of 14 positive BALs in the ventilated group but only in five of 13 positive BALs in the nonventilated group. This difference can be explained by the more aggressive treatment that was given to patients in group 2, including broad-spectrum antibiotics and amphotericin B.
The most frequent viral isolate was CMV, which was found in 13 of 86 BALs performed (15.1%). The rates of CMV isolation differed between groups 1 and 2 (9.7% and 20%, respectively). The 9.7% rate in the nonventilated patients is lower than reported in other studies (15-25%), 6, 7, 11 perhaps because of our routine use of preemptive gancyclovir in BMT patients with subclinical CMV infection to prevent CMV pneumonia. The onset of CMV pneumonitis is usually between 60 days and 6 months after BMT. 6 In our series, CMV was detected within less than 1 month after BMT in all the patients examined in both groups except one from group 1, in whom CMV was isolated 462 days after BMT. All the affected patients had received allogeneic BMTs, and 55.6% of them had undergone transplantation because of severe combined immune deficiency.
The impact of BAL was apparent when a treatable pathogen was isolated. In the present study, therapy was changed as a result of the BAL in 34.3% of cases, and in 84.6% of all positive BALs in group 1. Specific therapy was initiated in 22.5% of all the patients included in the study, and in 64.3% of the patients with positive BALs in group 2 based on the BAL findings. The results also led to a discontinuation of some empiric therapies, such as anti-PCP, in many other patients.
There was a significant difference between the groups in the timing of BAL after BMT, with median intervals of 255 days and 28.5 days in groups 1 group 2, respectively (P Ͻ 0.001). Acute respiratory failure developed relatively early after BMT, almost half the cases within the first month after BMT, similar to the reports of Warwick et al 14 (median BMT-BAL interval 30 days) and Rossi et al 15 (median 47 days).
The reported rates of life-threatening complications from bronchoscopy and BAL range from 0 to 15% in various studies of patients after BMT. 4, 8, 12, 13, 16 In the present study, only one serious peri-procedural complication of severe pulmonary hemorrhage occurred, in a nonventilated patient, several hours after BAL. Our 2.4% rate of severe complications in the nonventilated group, and the 1.1% rate for the whole series, is low.
The histologic findings on OLB correlated with the BAL findings in 66.7% of patients (six of nine OLBs). Three of the six patients had a negative BAL and noninfectious findings on OLB; in the other three, specific histologic findings of viral pneumonitis were found on OLB and viruses were detected in respiratory secretions. In one patient (11.1%), there was a clear disagreement between the BAL and OLB findings. These results are similar to those of Snyder et al 17 who reported a correlation of OLB and BAL findings in 67% of patients, and a false negative rate of 17%.
In conclusion, no difference in the yield of BAL was found between the ventilated and nonventilated post-BMT patients with pulmonary infiltrates. However, there was a significant difference in the type of isolates found in each group. The rate of severe complications was relatively low, and OLB and BAL findings were well correlated. The most important finding in this study was that change in therapy was dictated by BAL findings following one third of the procedures.
